| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Jun'15 | Jun'14 | Jun'13 |
|---|---|---|---|---|---|---|
Revenue | ||||||
1,122 | 59,505 | 37,833 | 14,198 | 9,871 | 825 | - |
Operating expenses | ||||||
Research and development | ||||||
97,501 | 98,269 | 87,388 | 63,789 | 24,137 | 9,575 | 7,495 |
General and administrative | ||||||
43,391 | 43,601 | 31,106 | 23,208 | 10,375 | 2,771 | 1,254 |
Total operating expenses | ||||||
140,892 | 141,870 | 118,494 | 86,997 | 34,512 | 12,346 | 8,749 |
Operating loss | ||||||
-139,770 | -82,365 | -80,661 | -72,799 | -24,641 | -11,521 | -8,749 |
Interest income | ||||||
2,772 | 2,849 | 2,230 | 1,110 | 504 | - | - |
Other income, net | ||||||
75 | -15,501 | 8,744 | 1,002 | 2,323 | -5 | 9 |
Total other income (expense), net | ||||||
- | - | - | - | - | - | 9 |
Loss before income taxes | ||||||
-136,923 | -95,017 | -69,687 | -70,687 | -21,814 | -11,526 | -8,740 |
Income tax expense | ||||||
242 | 497 | 451 | 892 | 244 | 75 | - |
Net loss attributable to ordinary shareholders | ||||||
-137,165 | -95,514 | -70,138 | -71,579 | -22,058 | -11,601 | -8,740 |
Deemed dividend on convertible preferred shares | ||||||
- | - | - | - | 14,735 | - | - |
Net loss attributable to ordinary shareholders | ||||||
- | - | -70,138 | -71,579 | -36,793 | -11,601 | -8,740 |
Net loss per ordinary share - Basic and diluted | ||||||
Basic and diluted (in dollars per share) | ||||||
-0.22 | -0.16 | -0.13 | -0.17 | -0.17 | -0.08 | -0.34 |
Weighted average shares outstanding: | ||||||
Basic and diluted (in shares) | ||||||
629,805 | 584,338 | 527,637 | 424,713 | 214,704 | 148,335 | 25,893 |
Development revenue | ||||||
Revenue | ||||||
1,122 | 20,391 | 37,833 | 14,198 | - | - | - |
License revenue | ||||||
Revenue | ||||||
- | 39,114 | - | - | - | - | - |